Successful use of empagliflozin in medically refractory post‐bariatric surgery hypoglycaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful use of empagliflozin in medically refractory post‐bariatric surgery hypoglycaemia

Published:2024-05 Issue:5 Volume:54 Page:836-837
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Park Yeung‐Ae¹²^ORCID,Chhabra Mahek³,Sim Ie‐Wen¹³⁴

Affiliation:

1. Department of Endocrinology and Diabetes Eastern Health Melbourne Victoria Australia

2. Department of Diabetes and Endocrinology Royal Melbourne Hospital Melbourne Victoria Australia

3. Department of Medicine School of Clinical Sciences, Monash University Melbourne Victoria Australia

4. Melbourne Medical School, University of Melbourne Melbourne Victoria Australia

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16401

Reference6 articles.

1. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies

2. SGLT inhibitors in management of diabetes

3. Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β

4. SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for Postprandial Hypoglycemia After Bariatric Surgery

5. Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP